<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activities of matrix metalloproteinases 2 and 7 and α1-proteinase inhibitor were measured in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Correlations between enzyme activity and the main parameters of carbohydrate metabolism were studied </plain></SENT>
<SENT sid="2" pm="."><plain>In patients, significant reduction of matrix metalloproteinase activity in the serum was noted, which correlated with the decrease in blood concentration of C-<z:chebi fb="7" ids="16670">peptide</z:chebi> (r=0.8) </plain></SENT>
<SENT sid="3" pm="."><plain>At the same time, serum activity of α1-proteinase inhibitor increased </plain></SENT>
<SENT sid="4" pm="."><plain>No significant relationships between patient's age, <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration, <z:chebi fb="0" ids="24103">fructosamine</z:chebi> concentration, and matrix metalloproteinase activity were observed </plain></SENT>
</text></document>